Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved ...

Neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS, Huntington’s disease, multiple sclerosis ...

The tumor microenvironment (TME) is a complex and dynamic ecosystem crucial for cancer progression and therapeutic response. Tumors actively shape this ...

National conference titled Connectomics-2025, focusing on the convergence of Omics, Bioinformatics, and Data Science for modern medical research, inaugurated ...

Chronic fatigue syndrome (also known as myalgic encephalomyelitis, or ME) is characterized by persistent fatigue, sleep ...

Senescent macrophages have been overlooked for too long. They're not just passive markers of aging—they actively reshape the ...

A new AI-based minimal classifier helps predict thyroid cancer subtypes and progression, contributing to a practical tailored ...

In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Alexander W. Charney describes how treating ...

Industry Veteran and Former Pfizer Chief Scientific Officer Brings Extensive R&D and Leadership Experience to Advance BenchSci's Mission of Improving the Speed and Quality of Preclinical R&D ...

New research reveals that genetic risk factors for Alzheimer's and stroke affect the brain's guardian blood vessels and ...

NEW YORK, New York, USA, 29 July 2025 – In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Alexander W. Charney ...